2012 Leaders in Science Seminars

13 August
Dr Mark Rubin
Rubin Lab, Department of Pathology, Weill Cornell Medical College, Cornell University, New York, USA
“Building Specifications for Precision Medicine: A prostate cancer pilot project”

10 September
Professor Edward Gelmann
Chief of the Division of Hematology and Oncology at Columbia University and New York Presbyterian Hospital
“NKX3.1 - The Gatekeeper Tumor Suppressor of Prostate Cancer”

17 September
Professor Richard Harvey
Victor Chang Cardiac Research Institute
“Character, Origins and Niche Regulation of Adult Cardiac MSC-like Stem Cells”

22 October
A/Professor Michael Buckley
Clinical Director, Genetics Laboratory, Prince of Wales Hospital
“Whole exome resequencing in the diagnosis of genetic disease: Practice and potential”

29 October
Professor Merlin Crossley
Dean, Faculty of Science, University of New South Wales
“Turning genes on and off”

5 November
Professor Kirill Alexandrov
ARC Future Fellow, Institute for Molecular Bioscience, University of QLD
“Optofluidic analysis of in vitro reconstituted protein complexes”

12 November
Professor Samuel Breit
Professor of Medicine, Director of Immunopathology and Head, Cytokine Biology and Inflammation Research Program, St Vincent’s Centre for Applied Medical Research (AMR), St Vincent's Hospital
“Birth, disease and death: the evolution of The TGF-b superfamily cytokine MIC-1/GDF15 from bench to clinic”

26 November
Professor Richard Lewis
Institute for Molecular Bioscience (QBP), The University of Queensland
“From Toxins to Drugs”

10 December
Professor Levon Khachigian
Director, UNSW Centre for Vascular Research, The University of New South Wales
“Growth regulatory transcriptional networks in vascular pathobiology”